Liquiritin Attenuates Lipopolysaccharides-Induced Cardiomyocyte Injury via an AMP-Activated Protein Kinase-Dependent Signaling Pathway

• প্রধান লেখক: Shan-Qi Mou (লেখক), Zi-Ying Zhou (লেখক), Hong Feng (লেখক), Nan Zhang (লেখক), Zheng Lin (লেখক), Xiahenazi Aiyasiding (লেখক), Wen-Jing Li (লেখক), Wen Ding (লেখক), Hai-Han Liao (লেখক), Zhou-Yan Bian (লেখক), Qi-Zhu Tang (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Background: Liquiritin (LIQ) is a traditional Chinese medicine that has been reported to regulate inflammation, oxidative stress and cell apoptosis. However, the beneficial effects of LIQ in lipopolysaccharides (LPS)-induced septic cardiomyopathy (SCM) has not been reported. The primary goal of this...